| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K19103580 |
| PharmacoGx | BRD-K19103580 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZNF786 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | ZNF793 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | ZNF827 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | ZNF853 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | ZNF92 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | ZP3 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | ZPLD1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | ZPR1 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | ZRANB1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | ZSCAN25 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
